VLPONC-01

N/A

Report date: 2026/04/13 20:02:18

Base Information

Drug NameVLPONC-01

Drug Alias NameVRP-encapsulated saRNA encoding IL-12VLPONC-01VRP-IL-12

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionInterleukin-12 replacements

TargetsInterleukin-12

Therapy Area/IndicationsSolid tumoursMouth NeoplasmsHead and Neck Neoplasms +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesVlp Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesVlp Therapeutics

Inactive CompaniesN/A

Active IndicationsSolid tumoursMouth NeoplasmsHead and Neck Neoplasms +[5]

Inactive IndicationsN/A

Other Information

ATC CodeN/A